|
FAM126B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33066907387547E-16 |
| Normal-vs-Stage2 |
3.35720340416401E-12 |
| Normal-vs-Stage3 |
1.62458935193399E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
4.453400E-01 |
| Stage1-vs-Stage3 |
2.047800E-02 |
| Stage1-vs-Stage4 |
6.400500E-04 |
| Stage2-vs-Stage3 |
3.323800E-02 |
| Stage2-vs-Stage4 |
2.459500E-03 |
| Stage3-vs-Stage4 |
1.324040E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.11630005239505E-09 |
| Normal-vs-Asian |
1.62969637784727E-12 |
| Caucasian-vs-AfricanAmerican |
4.964200E-01 |
| Caucasian-vs-Asian |
4.359800E-01 |
| AfricanAmerican-vs-Asian |
9.287600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
4.426800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.46620000002407E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.722800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.574770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.879600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.369400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.470400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.791200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.320300E-03 |
| Classical-VS-Follicular |
8.622100E-02 |
| Classical-VS-Other |
3.153200E-01 |
| Classical-VS-Normal |
1.62569957495862E-12 |
| Tall-VS-Follicular |
1.409850E-04 |
| Tall-VS-Other |
6.462400E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.583000E-01 |
| Follicular-VS-Normal |
3.48054918219987E-13 |
| Other-VS-Normal |
1.5734200000006E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.191170E-01 |
|
|
